Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Statement re Prospectus and Circular

20 Oct 2014 18:27

RNS Number : 8172U
Maven Income & Growth VCT PLC
20 October 2014
Β 

ο»Ώ

Joint Announcement

Prospectus and Circular

Maven Income and Growth VCT PLC ("Maven VCT 1"), Maven Income and Growth VCT 2 PLC ("Maven VCT 2"), Maven Income and Growth VCT 3 PLC ("Maven VCT 3"), Maven Income and Growth VCT 4 PLC ("Maven VCT 4") and Maven Income and Growth VCT 5 PLC ("Maven VCT 5") (together "the Companies" and each a "Company"). The Companies are managed by Maven Capital Partners UK LLP ("Maven").

The Boards of the Companies are pleased to announce the launch of the offers for subscription to raise, in aggregate, up to Β£18 million ("the Offers" and each an "Offer").

Full details of the Offers are contained in a prospectus ("the Prospectus"), which was published by the Companies today.

In contrast to previous offers by Maven VCTs, prospective investors can apply either to invest amounts of their choice in one or more of the Offers or invest an equal amount in each of the Companies pursuant to the Offers (subject to each relevant Offer not having closed prior to the Application Form being processed). The amount subscribed under each Offer will be invested into new ordinary shares of 10p each ("New Shares") in the relevant Company.

The Offers open today and will close at 12.00 noon on 28 April 2015 (unless fully subscribed by an earlier date or otherwise extended or closed at an earlier date at the Directors' discretion). Persons intending to apply under the Offers for the 2014/2015 tax year should note that the deadline for such applications is 12.00 noon on 1 April 2015.

Pursuant to individual offer agreements dated 20 October 2014 relating to each Offer between, among others, each relevant Company and Maven, Maven will receive a fee of an amount equal to 2.5% of the amounts remitted to each Company with an investor's application (including any amounts requested to be facilitated) in respect of applications accepted under that Offer less (i) an amount equal to any early investment incentive discounts being made available by the Company (as set out in the Prospectus) applicable in respect of applications accepted under the relevant Offer, and less (ii) any amounts that Maven has agreed to waive in respect of applications accepted under the relevant Offer. As Maven is a related party of each Company under the Listing Rules, the payment of such fee by each Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

Further, William Nixon and his associates have expressed their intention, prior to the close of the Offers, to subscribe for up to Β£300,000 under the Offers (up to Β£60,000 in respect of each Company). As a director (in the case of Maven VCT 2, Maven VCT 3 and Maven VCT 4) or an associate of Maven (in the case of Maven VCT 1 and Maven VCT 5), William Nixon and, therefore, each of his associates, are each a related party of each Company under the Listing Rules and consequently each of these subscriptions is a transaction to which Listing Rule 11.1.10R applies.

The Companies will also shortly be posting to shareholders a joint circular ("the Circular") convening general meetings of the Companies to be held on:

Β 

Β· 20 November 2014 at 10.00 a.m. (Maven VCT 1)

Β· 20 November 2014 at 10.15 a.m. (Maven VCT 2)

Β· 20 November 2014 at 10.30 a.m. (Maven VCT 3)

Β· 20 November 2014 at 10.45 a.m. (Maven VCT 4)

Β· 20 November 2014 at 11.00 a.m. (Maven VCT 5)

Β 

to propose, amongst other things, granting authorities to the Companies to allot New Shares pursuant to the Offers. The Prospectus has been submitted to the Financial Conduct Authority and copies of the Circular and Prospectus will shortly be available for download from the Companies' websites:

Β· www.mavencp.com/migvct

Β· www.mavencp.com/migvct2

Β· www.mavencp.com/migvct3

Β· www.mavencp.com/migvct4

Β· www.mavencp.com/migvct5

Β 

and from the National Storage Mechanism (http://www.hemscott.com/nsm.do).

For further information, please contact:Β 

Β 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

Β 

Β 

Β 

Maven Capital Partners UK LLP

Secretary

20 October 2014

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
STRBRBDGLDDBGSG
Date   Source Headline
28th Jan 202511:25 amRNSDirector/PDMR Shareholding
28th Jan 202510:39 amRNSIssue of Equity
24th Jan 202511:32 amRNSNet Asset Value(s)
29th Nov 20249:33 amRNSIssue of Equity - Dividend Investment Scheme
26th Nov 20243:51 pmRNSStatement re Dividend Investment Scheme
14th Nov 20242:51 pmRNSResult of General Meeting
24th Oct 20247:00 amRNSHalf-year Report
17th Oct 20244:27 pmRNSTransaction in Own Shares
16th Oct 20244:59 pmRNSTransaction in Own Shares
14th Oct 20243:25 pmRNSUnaudited Net Asset Value and Interim Dividend
27th Sep 20244:31 pmRNSPublication of a Prospectus
5th Sep 20244:45 pmRNSUnaudited Net Asset Value
19th Jul 20242:25 pmRNSIssue of Equity - Dividend Investment Scheme
18th Jul 20244:16 pmRNSTransaction in Own Shares
17th Jul 20245:03 pmRNSTransaction in Own Shares
15th Jul 20243:07 pmRNSStatement re Dividend Investment Scheme
15th Jul 20242:23 pmRNSStatement re Dividend Investment Scheme
12th Jul 20242:56 pmRNSNet Asset Value(s)
11th Jul 20241:38 pmRNSResult of AGM
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
31st May 20244:16 pmRNSFinal Results
16th May 20243:13 pmRNSTransaction in Own Shares
1st May 202410:02 amRNSIssue of Equity
26th Apr 20241:33 pmRNSUnaudited NAV & Proposed Final Dividend
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:47 pmRNSIssue of Equity
27th Mar 202410:34 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
21st Mar 20243:55 pmRNSStatement re Offer for Subscription
20th Mar 20243:44 pmRNSUnaudited Net Asset Value
8th Feb 202410:27 amRNSDirector/PDMR Shareholding
8th Feb 202410:26 amRNSDirector/PDMR Shareholding
8th Feb 202410:08 amRNSIssue of Equity
30th Jan 20245:09 pmRNSTransaction in Own Shares
17th Jan 20249:59 amRNSDirector/PDMR Shareholding
17th Jan 20249:57 amRNSIssue of Equity
15th Jan 20244:25 pmRNSUnaudited Net Value Asset
1st Dec 20239:39 amRNSIssue of Equity
24th Nov 202312:04 pmRNSStatement re Dividend Investment Scheme
9th Nov 20233:35 pmRNSResult of General Meeting
19th Oct 20234:51 pmRNSTransaction in Own Shares
18th Oct 20233:54 pmRNSHalf-year Report
13th Oct 20234:56 pmRNSPublication of a Prospectus
5th Oct 20234:39 pmRNSNet Asset Value and Interim Dividend
20th Jul 20234:32 pmRNSTransaction in Own Shares
14th Jul 20239:26 amRNSIssue of Equity
7th Jul 20234:17 pmRNSStatement re Dividend Investment Scheme
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
6th Jul 20233:37 pmRNSNet Asset Value
6th Jul 20231:06 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.